These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33571371)
81. Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder? Yang XJ; Lecksell K; Epstein JI Am J Clin Pathol; 1999 Nov; 112(5):649-53. PubMed ID: 10549252 [TBL] [Abstract][Full Text] [Related]
82. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors. Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123 [TBL] [Abstract][Full Text] [Related]
83. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Liu H; Shi J; Wilkerson ML; Lin F Am J Clin Pathol; 2012 Jul; 138(1):57-64. PubMed ID: 22706858 [TBL] [Abstract][Full Text] [Related]
84. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma. Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382 [TBL] [Abstract][Full Text] [Related]
85. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Bezerra SM; Lotan TL; Faraj SF; Karram S; Sharma R; Schoenberg M; Bivalacqua TJ; Netto GJ Hum Pathol; 2014 Aug; 45(8):1682-7. PubMed ID: 24925221 [TBL] [Abstract][Full Text] [Related]
86. Morphologic spectrum of estrogen receptor-negative breast carcinoma. Scawn R; Shousha S Arch Pathol Lab Med; 2002 Mar; 126(3):325-30. PubMed ID: 11860308 [TBL] [Abstract][Full Text] [Related]
87. Expression of retinoblastoma protein in breast cancer metastases to sentinel nodes: evaluation of its role as a marker for the presence of metastases in non-sentinel axillary nodes, and comparison to p16INK4a. Grupka NL; Bloom C; Singh M Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):63-70. PubMed ID: 16540733 [TBL] [Abstract][Full Text] [Related]
88. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer. Nährig J; Richter T; Kowolik J; Kuhn W; Avril N; Höfler H; Werner M Anticancer Res; 2000; 20(3B):2209-12. PubMed ID: 10928179 [TBL] [Abstract][Full Text] [Related]
89. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. Jensen JD; Knoop A; Ewertz M; Laenkholm AV Breast Cancer Res Treat; 2012 Apr; 132(2):511-21. PubMed ID: 21667123 [TBL] [Abstract][Full Text] [Related]
90. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry. Schoolmeester JK; Park KJ Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558 [TBL] [Abstract][Full Text] [Related]
91. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples. Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296 [TBL] [Abstract][Full Text] [Related]
92. Another variable in lymph node biopsy. Rogers LW; Ries SG Am J Clin Pathol; 2000 Aug; 114(2):293-5. PubMed ID: 10941348 [No Abstract] [Full Text] [Related]
93. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study. Catteau X; Simon P; Noël JC Diagn Pathol; 2014 Oct; 9():196. PubMed ID: 25339428 [TBL] [Abstract][Full Text] [Related]
94. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level. Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926 [TBL] [Abstract][Full Text] [Related]